June 1, 2026 GenRPT Finance
Investment analysts are rebuilding revenue projections for medical device companies...
GLP-1 adoption rates have become a cross-sector variable because their...
GLP-1 drugs are no longer just a pharmaceutical success story....
Equity research automation is helping analysts track nuclear regulatory approval...
Traditional comparable analysis often fails when valuing Small Modular Reactor...
Financial modeling for power companies has changed because nuclear assets...
Nuclear capacity commitments have become a valuation-moving input because they...
Nuclear power is making a comeback, and it is forcing...
May 29, 2026 GenRPT Finance
AI in Banking is dramatically improving counterparty exposure calculation speed...
Finance automation has significantly improved collateral management and margin operations,...
